Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd.

Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. is located in Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai. It serves as the drug R&D center in Shanghai for the listed company Health Element Pharmaceutical Group Co., Ltd. (stock code: 600380). Health Element Pharmaceutical Group Co., Ltd. is a comprehensive pharmaceutical enterprise, owning two listed companies, Health Element and Livzon Pharmaceutical, along with seven holding companies, two national-level R&D centers, and three provincial-level R&D centers. In 2014, Shanghai Fangyu Health Pharmaceutical Technology Co., Ltd. was approved by the Shanghai Municipal Science and Technology Commission to establish the "Shanghai Professional Technical Service Platform for Respiratory Drug Delivery," and cooperated with the Shanghai Food and Drug Packaging Material Testing Institute to jointly build the "Shanghai Professional Technical Service Platform for Drug Compatibility Research." Targeting therapeutic drugs for major diseases such as respiratory diseases, tumors, diabetes, and infectious diseases, the company aims to develop high-quality new formulations and innovative drugs through independent research and collaboration with first-class domestic and international universities and pharmaceutical R&D and manufacturing enterprises, with a primary focus on developing high-difficulty respiratory drug delivery system products. The company boasts an R&D team composed of researchers, PhDs, masters, and bachelors, equipped with over 20 million yuan of professional equipment, creating first-class experimental conditions.